Galocitabine
Code | Size | Price |
---|
TAR-T27399-1mg | 1mg | £335.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T27399-5mg | 5mg | £711.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T27399-10mg | 10mg | £946.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T27399-25mg | 25mg | £1,396.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T27399-50mg | 50mg | £1,862.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T27399-100mg | 100mg | £2,424.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Images
Documents
Further Information
Bioactivity:
Galocitabine, a thymidylate synthase inhibitor, is used potentially for the treatment of cancer.
CAS:
124012-42-6
Formula:
C19H22FN3O8
Molecular Weight:
439.396
Purity:
0.98
SMILES:
COc1cc(cc(OC)c1OC)C(=O)Nc1nc(=O)n(cc1F)[C@@H]1O[C@H](C)[C@@H](O)[C@H]1O
References
1. Shindoh H, Kawashima A, Shishido N, Nakano K, Kobayashi K, Horii I. Relationship between AUC of 5'-DFUR and toxicity of capecitabine, fluoropyrimidine carbamate analogs, and 5'-DFUR in monkeys, mice, and rats. J Toxicol Sci. 2006 Aug;31(3):265-85. PubMed PMID: 16960436.
2. Funaki T, Onodera H, Ogawa K, Ichihara S, Fukazawa H, Kuruma I. Simultaneous determination of a new anticancer drug galocitabine and its metabolites in blood by high-performance liquid chromatography. J Pharm Biomed Anal. 1993 Apr-May;11(4-5):379-84. PubMed PMID: 8357875.